Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 May 2022 | Story Leonie Bolleurs | Photo Charl Devenish
Prof Tomas Vetrik
Prof Tomas Vetrik, Professor in the Department of Mathematics and Applied Mathematics, recently delivered his inaugural lecture on the UFS Bloemfontein Campus.

Prof Tomas Vetrik, Professor in the Department of Mathematics and Applied Mathematics at the University of the Free State (UFS), recently delivered his inaugural lecture on the Bloemfontein Campus.

His research area is graph theory, and he mainly focuses on the degree-diameter problem, graph indices, and metric dimension of graphs.

Research focus

According to Prof Vetrik, mathematics was always his favourite subject in school. He also excelled in maths at university and decided to enrol for a course on graph theory while working on his master’s degree. “I liked it, so I also chose topics from graph theory for my PhD thesis,” he says.

In 2014, at the age of 32, he was appointed Associate Professor at the UFS, after postdoctoral research at the University of KwaZulu-Natal and working at the University of Pretoria. An NRF-rated researcher, he has published close to 75 research papers, a third of that as a single author in some of the most well-known journals in his area. Moreover, he was also research supervisor of three PhD and three master’s students.

International collaborations

In the eight years since his appointment at the UFS, Prof Vetrik has made research visits to universities from 14 different countries that have invited him for research collaborations. 

“I am often overseas. I like working from different places. It is interesting to me, and it helps me to be productive,” says Prof Vetrik, explaining some of the inspiration behind his mathematical ideas.

In the next two years, he would like to study more general mathematical problems beyond his current research area.

He says he is addicted to his research. “It overshadows all my other interests.” 

On the rare occasion when he is not working on his research, Prof Vetrik states that he has to keep himself busy. Unable to relax and do nothing, he likes to do sports of some kind or to travel. 

“I am a simple person. I do not even have a TV at home. I use an old-fashioned mobile phone that cannot access the internet,” he says.


News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept